Bortezomib as therapy for mixed humoral and cellular rejection: should it be first line?

MeSH terms

• B-Lymphocytes / immunology
• Boronic Acids / therapeutic use*
• Bortezomib
• Creatinine / blood
• Follow-Up Studies
• Graft Rejection / immunology
• Graft Rejection / prevention & control*
• Hepatitis C / complications
• Humans
• Immunity, Cellular
• Immunity, Humoral
• Immunoglobulins, Intravenous / therapeutic use
• Kidney Failure, Chronic / complications
• Kidney Failure, Chronic / surgery*
• Kidney Transplantation / immunology*
• Male
• Middle Aged
• Protease Inhibitors / therapeutic use*
• Pyrazines / therapeutic use*
• T-Lymphocytes / immunology